Thermo Fisher Scientific
168 Third Avenue
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer.
Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them.
Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
Stock Symbol: TMO
1663 articles about Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Morgan Stanley 2022 Global Healthcare Conference on Monday, September 12, 2022, at 9:55 a.m. (EDT).
Thermo Fisher Scientific Showcases Latest Innovations to Improve Biopharmaceutical and Proteomics Workflows
Thermo Fisher Scientific Inc., the world leader in serving science, is showcasing a new mass spectrometry instrument and consumables that enable biopharmaceutical and proteomics customers to drive scientific breakthroughs and solve analytical challenges.
Sonoma Bio announced its plans to erect an 83,000-square-foot operations facility in Seattle, while Thermo Fisher opened a new viral vector manufacturing plant in Massachusetts.
Society for Science (the Society) and Thermo Fisher Scientific Inc., the world leader in serving science, today announced that Thermo Fisher will be the new title sponsor of the Society's middle school STEM (science, technology, engineering and math) competition, the nation's premier STEM competition.
New Line of Electrochemistry Bench Meters Simplify pH, Conductivity and Dissolved Oxygen Measurement
Academic and industry laboratories now have access to a new line of electrochemistry bench meters from Thermo Fisher Scientific that have been designed to easily record accurate measurements of pH, conductivity and dissolved oxygen.
Thermo Fisher Scientific, the world leader in serving science, expanded its cell and gene therapy capabilities with the opening of its new previously announced viral vector manufacturing facility in Plainville, Mass.
Thermo Fisher Scientific’s Largest Single-Use Technology Manufacturing Site Opens in Greater Nashville
Thermo Fisher Scientific Inc., the world leader in serving science, opened its largest single-use technology manufacturing site in Greater Nashville.
The FDA is busy accepting drug applications, granting specialty designations and approving drugs for market. Here's a look at this week's FDA activity.
Today, Thermo Fisher Scientific announces the clearance of ImmunoCAP Specific IgE (sIgE) Allergen Components for wheat and sesame* allergies by the U.S. Food & Drug Administration (FDA) for in vitro diagnostic use.
FDA Approves First NGS-Based Companion Diagnostic to Aid in Selecting Non-Small Cell Lung Cancer Patients with HER2 (ERBB2) Activating Mutations (SNVs & Exon 20 Insertions) for Treatment with ENHERTU
The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients whose tumors have a HER2 (ERBB2) activating mutations (SNVs & Exon 20 Insertion) in non-small cell lung cancer (NSCLC).
Thermo Fisher Scientific, the world leader in serving science, today announced the launch of its Applied Biosystems HIV-1 Genotyping Kit with Integrase, a research use only assay that examines positive samples of human immunodeficiency virus (HIV) to identify genetic variants that resist common antiretrovial therapeutics.
Thermo Fisher Scientific Introduces Highly Sensitive Research Assays for Measurable Residual Disease Detection in Myeloid Malignancies
Thermo Fisher Scientific today launched a next-generation sequencing (NGS)-based assay for research in myeloid measurable residual disease (MRD).
Thermo Fisher Scientific Inc., the world leader in serving science, enables clinical research, toxicology and anti-doping laboratories performing dried spot sampling and analysis to utilize a new automated sample prep and ultra-high-performance liquid chromatography system to improve efficiency, robustness, sensitivity and sample traceability.
Thermo Fisher Scientific and Structura Biotechnology Collaborate to Offer a Solution for Real-Time Cryo-EM Data Analysis
Thermo Fisher Scientific Inc. and Structura Biotechnology Inc. today announced a collaboration to make available a new single particle analysis software solution, a version of Structura’s CryoSPARC Live.
Thermo Fisher Scientific Opens Oncomine Clinical Research Grant Call for Submissions and Announces Latest Awardees
As part of its continued commitment to expand the benefits of next-generation sequencing (NGS), Thermo Fisher Scientific is now accepting submissions for the fifth round of the Oncomine Clinical Research Grant program.
Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Thermo Scientific Arctis Cryo-Plasma Focused Ion Beam (Cryo-PFIB), a new connected and automated microscope designed to advance the pace of cryo-electron tomography (cryo-ET) research.
Thermo Fisher Scientific Inc., the world leader in serving science, reported its financial results for the second quarter ended July 2, 2022.
The U.S. Attorney’s Office was busy indicting nine people for charges related to insider trading. Some charges were unrelated, but three were specific to the biopharma industry.
Thermo Fisher Scientific Inc., the world leader in serving science, is showcasing innovative diagnostic technologies, assays and a complement of solutions for researchers developing new diagnostics.
Sanofi, Certara, Pfizer and Thermo Fisher are facing hiring challenges head-on with a common strategy: upskilling programs. They use these programs to fill open roles while training and retaining existing talent.